Generic name: Rivaroxaban
Pharmacologic Category: Anticoagulant
Dosage Form: Oral Film-coated tablet, 2.5 mg
Rivaroxaban is a highly selective direct factor Xa inhibitor with high oral bioavailability. Inhibition of factor Xa interrupts the intrinsic and extrinsic pathway of the blood coagulation cascade, inhibiting both thrombin formation and development of thrombi.
• Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg) alone or with ASA plus clopidogrel, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (ACS) with elevated cardiac biomarkers
• Axabin 2.5mg, co-administered with low dose Aspirin (75– 100 mg), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (CAD) or symptomatic peripheral artery disease (PAD) at high risk of ischemic events.
- Axabin® is the first generic form of rivaroxaban in Iran which is produced at a GMP approved manufacturing site
Did you know more than 27 per 1000 diabetic patients were died annually caused by cardiovascular diseases?
Did you know, throughout the world, it is estimated that every 30 seconds a leg is amputated and 85% of these amputations are the result of peripheral artery disease and diabetic foot ulcer?